EN
Cochleate Novel Drug Delivery System
Abstract
In contemporary times, novel drug delivery systems play a crucial role in facilitating the effective and safe transportation of drugs to their target sites, thus holding significant importance in research. Many active pharmaceutical ingredients suffer from low oral bioavailability because of their poor solubility in water and challenges in traversing biological membranes. To enhance therapeutic efficacy and mitigate side effects in formulations of such drugs with low oral bioavailability, numerous drug delivery systems have been developed. The most commonly elucidated systems are micelles, liposomes, dendrimers, nanocapsules, and nanospheres. Lipid-based drug delivery systems are pivotal platforms that facilitate the transport of drugs to target tissues, enhance solubility, and improve bioavailability. These systems leverage the inherent properties of lipids to facilitate drug transport. Notably, cochleates are lipidic structures that deserve particular attention within these systems. Cochleates are spiral structures formed as a result of the interaction of calcium ions with negatively charged phospholipids. These lipidic structures play a significant role in drug transport by protecting, stabilising, and facilitating the delivery of drugs to the intended tissue.
This review discusses various aspects of cochleate, including their structure, formation, preparation, utilisation as drug carriers, impact on bioavailability, and future potential. Additionally, the current status and future prospects of cochleate will be evaluated.
This study provides a comprehensive overview of the advantages and potential applications of cochleate in drug delivery.
Keywords
References
- Ağardan, N. B. M., Değim, Z., Yılmaz, Ş., Altıntaş, L., & Topal, T. (2016). The effectiveness of raloxifene-loaded liposomes and cochleates in breast cancer therapy. AAPS Pharm Sci Tech, 17, 968-977. google scholar
- Ahiwale, R. J., Chellampillai, B., & Pawar, A. P. (2022). Investigation of novel sorafenib tosylate loaded biomaterial based nano-cochleates dispersion system for treatment of hepatocellular carcinoma. Journal of Dispersion Science And Technology, 43(10), 1568-1586. google scholar
- Asprea, M., Tatini, F., Piazzini, V., Rossi, F., Bergonzi, M. C., & Bilia, A. R. (2019). Stable, monodisperse, and highly cell-permeating nanocochleates from natural soy lecithin liposomes. Pharmaceutics, 11(1), 34. google scholar
- Batista-Duharte, A., Lastre, M., Romeu, B., Portuondo, D. L., Téllez-Martínez, D., Manente, F. A., … & Carlos, I. Z. (2016). Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii. International Immunopharmacology, 40, 277-287. google scholar
- Bothiraja, C., Rajput, N., Poudel, I., Rajalakshmi, S., Panda, B., & Pawar, A. (2018). Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup1), 447-461. google scholar
- Bothiraja, C., Yojana, B. D., Pawar, A. P., Shaikh, K. S., & Thorat, U. H. (2014). Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opinion On Drug Delivery, 11(1), 17-29. google scholar
- Bozó, T., Wacha, A., Mihály, J., Bóta, A., & Kellermayer, M. S. (2017). Dispersion and stabilization of cochleate nanoparticles. European Journal Of Pharmaceutics And Biopharmaceutics, 117, 270-275. google scholar
- Castro, A. L., Pomel, S., Cailleau, C., Fournier, N., Dennemont, I., Loiseau, P. M., & Barratt, G. (2022). Pharmacokinetics, biodistribution, and activity of amphotericin B-loaded nanocochleates on the Leishmania donovani murine visceral leishmaniasis model. International Journal Of Pharmaceutics, 624, 121985. google scholar
Details
Primary Language
English
Subjects
Pharmaceutical Delivery Technologies
Journal Section
Review
Publication Date
January 14, 2026
Submission Date
August 10, 2024
Acceptance Date
September 16, 2024
Published in Issue
Year 2025 Volume: 55 Number: 3
APA
Erdoğan, Ü., & Özsoy, Y. (2026). Cochleate Novel Drug Delivery System. İstanbul Journal of Pharmacy, 55(3), 511-518. https://doi.org/10.26650/IstanbulJPharm.2025.1531344
AMA
1.Erdoğan Ü, Özsoy Y. Cochleate Novel Drug Delivery System. iujp. 2026;55(3):511-518. doi:10.26650/IstanbulJPharm.2025.1531344
Chicago
Erdoğan, Ünnügülsüm, and Yıldız Özsoy. 2026. “Cochleate Novel Drug Delivery System”. İstanbul Journal of Pharmacy 55 (3): 511-18. https://doi.org/10.26650/IstanbulJPharm.2025.1531344.
EndNote
Erdoğan Ü, Özsoy Y (January 1, 2026) Cochleate Novel Drug Delivery System. İstanbul Journal of Pharmacy 55 3 511–518.
IEEE
[1]Ü. Erdoğan and Y. Özsoy, “Cochleate Novel Drug Delivery System”, iujp, vol. 55, no. 3, pp. 511–518, Jan. 2026, doi: 10.26650/IstanbulJPharm.2025.1531344.
ISNAD
Erdoğan, Ünnügülsüm - Özsoy, Yıldız. “Cochleate Novel Drug Delivery System”. İstanbul Journal of Pharmacy 55/3 (January 1, 2026): 511-518. https://doi.org/10.26650/IstanbulJPharm.2025.1531344.
JAMA
1.Erdoğan Ü, Özsoy Y. Cochleate Novel Drug Delivery System. iujp. 2026;55:511–518.
MLA
Erdoğan, Ünnügülsüm, and Yıldız Özsoy. “Cochleate Novel Drug Delivery System”. İstanbul Journal of Pharmacy, vol. 55, no. 3, Jan. 2026, pp. 511-8, doi:10.26650/IstanbulJPharm.2025.1531344.
Vancouver
1.Ünnügülsüm Erdoğan, Yıldız Özsoy. Cochleate Novel Drug Delivery System. iujp. 2026 Jan. 1;55(3):511-8. doi:10.26650/IstanbulJPharm.2025.1531344